EntryPoint Capital »

Amylyx Pharmaceuticals shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $233k 17k 13.59
2025-03-31 $38k 11k 3.54
2024-12-31 $53k 14k 3.78